Aurinia Pharmaceuticals Inc.
Status: Publicly traded
Direct answer
Aurinia Pharmaceuticals Inc. is publicly traded on NASDAQ under the ticker AUPH.
Aurinia Pharmaceuticals Inc. operates as a commercial-stage biopharmaceutical company, specializing in the development and commercialization of innovative therapies. Its core mission is to address a variety of diseases for which current medical solutions are inadequate, serving patient populations across the United States and internationally. The company's flagship product is LUPKYNIS, an approved treatment designed...
Can you invest in Aurinia Pharmaceuticals Inc.?
Yes. Aurinia Pharmaceuticals Inc. is publicly traded on NASDAQ under the ticker AUPH.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Aurinia Pharmaceuticals Inc.
Detailed equity research is provided by MarketSnap.